Fort Washington Investment Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Fort Washington Investment Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-17,325	Closed	-$934K	–	599
2017 Q4	$934K	Sell	17,325 -12	-0.1%	-$657	0.01%	413
2017 Q3	$989K	Sell	17,337 -4,208	-20%	-$246K	0.02%	317
2017 Q2	$1.3M	Sell	21,545 -1,595	-7%	-$90.8K	0.02%	273
2017 Q1	$1.26M	Buy	+23,140	New	+$1.14M	0.02%	289

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Fort Washington Investment Advisors's BIVV Position: Q1 2018 in Review

Fort Washington Investment Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 17,325 shares — an estimated $934K sold.

Fort Washington Investment Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.3M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Fort Washington Investment Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Fort Washington Investment Advisors sold 17,325 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $934K.
Fort Washington Investment Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Fort Washington Investment Advisors's Bioverativ Inc. Common Stock position peaked at $1.3M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Fort Washington Investment Advisors's 13F filing for Q1 2018, filed 2 May 2018.